Chronic Myeloproliferative Disorders  >>  pioglitazone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
ACTIM, NCT02888964: Pioglityazone and Imatinib for CML Patients

Completed
2
27
Europe
Add-on therapy
Versailles Hospital
Leukemia, Myeloid, Chronic-Phase
02/12
02/16
NCT02730195: Pioglitazone and Tyrosine Kinase Inhibitor in Treating Patients With Relapsed Chronic Myeloid Leukemia

Terminated
2
9
US
Pioglitazone, Actos, Pioglitazone Hydrochloride, Tyrosine Kinase Inhibitor (TKI), Protein Tyrosine Kinase Inhibitors, PTK Inhibitors, TK Inhibitors
Emory University
Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive
07/18
07/18

Download Options